Browse Technologies by  


UPN Ref Technology
47 In-vitro model to simulate digestion
In-vitro static digestion model to evaluate the bioavailability, bioaccessibility and beneficial effects of proteins, single compounds, complex formulations and nanoparticles.
View Technology
44 DNA Aptamers and Aptamer-Based Diagnostics
The Innovator is selling some of its patented or patent-pending aptamers to the public R&D community. The Innovator has also leveraged funds to produce a new portable (G2 FLASH) reader for its DNA aptamer-magnetic bead sandwich and FRET-aptamer assays. The assays are either developed already or are in development for the major foodborne pathogenic bacteria (Campylobacter, E. coli O157:H7, Salmonella, and Listeria) and clinical analytes such as bone loss (osteoporosis) and cardiovascular markers.
View Technology
40 A bacteriophage lysates production technology
A method for the commercial production of bacteriophages composition. The method decreases the production volume and increases the production yields.
View Technology
35 Advanced in-vitro model to evaluate the disposition and bio-performance of oral pharmaceuticals and nutritional products.
A dynamic in-vitro system that fully replicates the complex biochemical conditions and the array of gastric forces crucial for the prediction of the bio-performance of pharmaceuticals and nutritional based materials.
View Technology
7 In vitro 3D skin model technology
A highly reproducible full thickness primary human skin equivalent, uniquely capable of the surface growth of skin microorganisms in their natural state. It is used as a high-grade research platform for the testing of active ingredients and topical formulations for claims support in all areas of dermatology, skin care and cosmetics. The highly defined structure and responsive biology provides opportunities for far more sophisticated and predictive experimentation than simpler, less capable models and human and porcine ex-vivo materials.
View Technology
slider